Literature DB >> 21549449

[Physiopathology of acute renal failure during sepsis].

T Regueira1, M Andresen, M Mercado, P Downey.   

Abstract

Acute renal failure (ARF) is an independent risk factor associated with increased mortality during sepsis. Recent consensus definitions have allowed the standardization of research on the subject. The understanding of the physiopathology of ARF during sepsis is limited by the scarcity of histological studies and the inability to measure renal microcirculatory flows. Historically, ARF during sepsis has been considered to be a consequence of diminished renal blood flow (RBF). Indeed, in early stages of sepsis or in sepsis associated to cardiogenic shock, RBF may decrease. However, recent studies have shown that in resuscitated sepsis, in which cardiac output is characteristically normal or even elevated and there is systemic vasodilatation, RBF is normal or even increased, with no associated histological evidence of significant tubular necrosis. Thus, other factors may participate in the genesis of ARF in sepsis. These include apoptosis, glomerular and medullary microcirculatory disorders, cell changes in response to the pro-inflammatory cascade characteristic of sepsis, oxidative stress, mitochondrial dysfunction and damage induced by mechanical ventilation, among others. Sepsis associated ARF treatment is supportive. In general, renal replacement therapies can be grouped as intermittent or continuous, and as those whose primary objective is the replacement of impaired renal function, versus those whose main objective is to secure hemodynamic stability through the clearing of pro-inflammatory mediators.
Copyright © 2010 Elsevier España, S.L. y SEMICYUC. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549449     DOI: 10.1016/j.medin.2011.03.011

Source DB:  PubMed          Journal:  Med Intensiva        ISSN: 0210-5691            Impact factor:   2.491


  7 in total

Review 1.  Role of microRNA in the detection, progression, and intervention of acute kidney injury.

Authors:  Yan-Fang Zou; Wen Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-21

2.  Inhibition of ALDH2 expression aggravates renal injury in a rat sepsis syndrome model.

Authors:  Jun-Feng Hu; Hua-Xue Wang; Hui-Hui Li; Jie Hu; Ying Yu; Qin Gao
Journal:  Exp Ther Med       Date:  2017-07-12       Impact factor: 2.447

3.  Identification of phosphorylated MYL12B as a potential plasma biomarker for septic acute kidney injury using a quantitative proteomic approach.

Authors:  Fan Wu; Xiu-Juan Dong; Yan-Yan Li; Yan Zhao; Qiu-Lin Xu; Lei Su
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  Antithrombin III expression predicts acute kidney injury in elderly patients with sepsis.

Authors:  Yun Xie; Rui Tian; Wei Jin; Hui Xie; Jiang Du; Zhigang Zhou; Ruilan Wang
Journal:  Exp Ther Med       Date:  2019-12-09       Impact factor: 2.447

5.  The association between continuous renal replacement therapy as treatment for sepsis-associated acute kidney injury and trend of lactate trajectory as risk factor of 28-day mortality in intensive care units.

Authors:  Zichen Wang; Luming Zhang; Fengshuo Xu; Didi Han; Jun Lyu
Journal:  BMC Emerg Med       Date:  2022-02-28

6.  Omega-9 Oleic Acid Induces Fatty Acid Oxidation and Decreases Organ Dysfunction and Mortality in Experimental Sepsis.

Authors:  Cassiano Felippe Gonçalves-de-Albuquerque; Isabel Matos Medeiros-de-Moraes; Flora Magno de Jesus Oliveira; Patrícia Burth; Patrícia Torres Bozza; Mauro Velho Castro Faria; Adriana Ribeiro Silva; Hugo Caire de Castro-Faria-Neto
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

7.  Epidemiology of acute kidney injury and chronic kidney disease in the intensive care unit.

Authors:  Darwin Tejera; Fernanda Varela; Daniela Acosta; Stephanie Figueroa; Sebastián Benencio; Cristina Verdaguer; Mauricio Bertullo; Federico Verga; Mario Cancela
Journal:  Rev Bras Ter Intensiva       Date:  2017-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.